Search





Search





Markets
/
Stocks
/
avtx
/

Avalo Therapeutics Inc

AVTX

Add to Watchlist

17.600USD

-0.160-0.90%

Close 07-23 16:00（ET）Quotes delayed by 15 min

433.63MMarket Cap

LossP/E TTM

Avalo Therapeutics Inc

17.600

-0.160-0.90%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-23

Previous score

5.00

Change

The current institutional shareholding score of Avalo Therapeutics Inc is 5.00, ranking 132 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 60.06%, representing a quarter-over-quarter increase of 20.42%. The largest institutional shareholder is Steven Cohen, holding a total of 866.37K shares, representing 3.72% of shares outstanding, with 27.87% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

2.13M

+864.97%

BVF Partners L.P.

1.36M

+0.00%

Nantahala Capital Management, LLC

1.24M

OrbiMed Advisors, LLC

1.19M

-12.01%

UBS Financial Services, Inc.

477.82K

+956.93%

Affinity Asset Advisors LLC

1.05M

Millennium Management LLC

934.43K

+3.16%

Caligan Partners, LP

881.53K

+5.78%